Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis.

Johnson, Brian B; Beck, Lisa A; Mustafa, S Shahzad

Johnson, Brian B; Beck, Lisa A; Mustafa, S Shahzad.

Afiliación

Johnson BB; Department of Dermatology, University of Rochester Medical Center, Rochester, New York.
Beck LA; Department of Dermatology, University of Rochester Medical Center, Rochester, New York.
Mustafa SS; Department of Allergy, Immunology, and Rheumatology, Rochester Regional Health, Rochester, New York.

JAAD Case Rep ; 5(7): 605-608, 2019 Jul.

Article en En | MEDLINE | ID: mdl-31338403

Palabras clave

AD, atopic dermatitis; CsA, cyclosporine; IL, interleukin; NB-UVB, narrow-band ultraviolet B; QoL, quality of life; SCORAD, SCORing Atopic Dermatitis; atopic dermatitis; biologic; dupilumab; eczema

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: JAAD Case Rep Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google